The global pneumonia testing market size hit USD 557.1 million in 2021. The market valuation is slated to rise from USD 606.6 million in 2022 to USD 912.5 million by 2029, recording 6% CAGR during 2022-2029. This information is provided by Fortune Business Insights in its report titled “Pneumonia Testing Market, 2022-2029”. Key Industry Development: April 2022: bioMérieux SA acquired Specific Diagnostics, a company that developed a rapid Antimicrobial Susceptibility Test (AST) system that directly delivers phenotypic AST from positive blood cultures. Request a Sample Copy of the Research Report: Regional Insights: The North American Market Stood at USD 221.4 Million in 2021 North America dominated the pneumonia testing market share in 2021 with USD 221.4 million. The region will continue to hold the dominant market share through 2029 led by growing pneumonia cases, rapid adoption of point-of-care technologies, and supportive reimbursement policies. The European market holds the second-largest market share and will experience growth led by growing number of hospital admissions related to pneumonia. Meanwhile, the market in Asia Pacific will grow on account of a large geriatric population. To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: About Us: Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. Contact Us: Fortune Business Insights Pvt. Ltd. 9th Floor, Icon Tower, Baner – Mahalunge Road, Baner, Pune-411045, Maharashtra, India. Phone: US :+1 424 253 0390 UK : +44 2071 939123 APAC : +91 744 740 1245